BioProgress - The intraday chat, banter, abuse & general talk-shite thread

if you were a betting man... only the month of august this year doesnt have an RNS. every month in 2004 had an RNS

29/11/05 Appointment of Non Executive Director
28/11/05 Resignation of director
22/11/05 Notification of major interests in shares
14/11/05 Change of Adviser and Broker
03/11/05 Appointment of new advisor
02/11/05 Grant of Executive and Employee Options
03/10/05 Notification of major interests in shares
27/09/05 Interim Results for the six months to 30 June 2005
26/09/05 Notification of major interests in shares
29/07/05 Appointment of Chairman
27/07/05 Issue of Equity
22/06/05 Result of AGM
22/06/05 AGM Statement
13/06/05 Peter Glynn-Jones
07/06/05 Issue of Equity / Redemption of Convertible Bond
07/06/05 Update on partnership developments
01/06/05 Redemption of convertible bonds
31/05/05 Strategic and Financial Review
27/05/05 Notification of AGM
23/05/05 CEO Appointment
04/05/05 Update on Board Director
03/05/05 Notification of major interests in shares
03/05/05 Notification of major interests in shares
29/04/05 Director Change
13/04/05 Trading Update
21/03/05 Preliminary Results for the year ended 31 December 2004
07/03/05 Appointment of Finance Director
04/03/05 Notice of results
03/03/05 BioProgress places £1.5 million order to build the first commercial TABWRAP™ machine
15/02/05 Changes to the Board
11/02/05 New patent granted
10/02/05 BioProgress signs contract with Custom Pharmaceuticals for new UK pharmaceutical film manufacturing facility and appoints Callisto Consulting to progress US and European medicines product license applications


oh... and january


20/12/04 Additional Listing
09/12/04 Damages assessment to proceed in High Court case
22/11/04 BioProgress signs agreement with University of Cambridge for new micro-capillary film technology
18/11/04 Trading Update
09/11/04 BioProgress reaches agreement to provide new UK film manufacturing capacity and unveils new ‘LOCUM’ virtual manufacturing strategy
03/11/04 Further success for BioProgress in patent entitlement case
21/10/04 CORRECTION - Exercise of options by director
21/10/04 BioProgress announces China supply agreement with AXM Pharma, Inc. (“AXM Pharma”)
21/10/04 NASDAQ listing
20/10/04 Exercise of options by director
20/10/04 NASDAQ listing
18/10/04 Director shareholding
08/10/04 Convertible bond exercise price
05/10/04 Exercise of options and warrants by directors
01/10/04 High Court victory for BioProgress in Patent Entitlement case
01/10/04 Up to £10 million fund raising via convertible bond issue
29/09/04 Interim Results for the six months to 30 June 2004
14/09/04 New patent granted
13/09/04 Notice of results and update on NASDAQ listing
24/08/04 Colgate Palmolive launches new toothpaste in US using BioProgress’ Soluleaves™ technology
23/08/04 BioProgress announces option agreement with Micap plc (“Micap”)
17/08/04 BioProgress increases production capacity with purchase of two soluble film casting lines
04/08/04 BioProgress appoints JPMorgan for US Nasdaq listing
12/07/04 Pre-close statement
05/07/04 BioProgress names Perrigo as the US pharmaceutical company which signed a global licensing agreement for TABWRAP®
30/06/04 Statement re: Berlin-Bremen Stock Exchange
14/06/04 Grant of Options and strengthening of the management team
10/06/04 NASDAQ listing
07/06/04 Exclusive licensing option agreement with Wyeth for XGEL® SWALLOW liquid fill capsule technology
03/06/04 Update on FMC BioPolymer Global Licensing Agreement
28/05/04 Board Change
30/04/04 Exercise of options and warrants by directors
26/04/04 Response statement re: Mr George Tidy
21/04/04 Update on BioTec Films LLC
21/04/04 AGM statement and senior management appointment at BioTec Films LLC
01/04/04 Exercise of options and warrants
18/03/04 Letter to Shareholders
08/03/04 BioProgress announces the signing of a global licensing agreement for TABWRAP® one of the new XGEL® dosage forms
08/03/04 Definitive agreement to acquire certain assets of Aquafilm LLC
08/03/04 Preliminary Results – Monday 8 March 2004
04/02/04 FMC BioPolymer and BioProgress execute a multi-million dollar Global Licensing Agreement
15/01/04 Share options exercised and management team strengthened